top of page
Orthocell Secures Landmark US FDA Clearance for Remplir™, Unlocking US Market
Orthocell (ASX: OCC) has received US FDA 510(k) clearance for its nerve repair product, Remplir™, opening access to the US$1.6 billion US...
Apr 4
bottom of page